Rubicon Organics Inc.
$0.43+1.16%(+$0.01)
TickerSpark Score
58/100
80
Valuation
30
Profitability
95
Growth
56
Health
30
Momentum
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a ROMJ.V research report →
52-Week Range13% of range
Low $0.39
Current $0.43
High $0.73
Companywww.rubiconorganics.com
Rubicon Organics Inc. produces and sells organic cannabis for the recreational and medical-use markets in Canada. The company processes and sells organic cannabis under its wholly owned and other licensed brands.
- CEO
- Margaret Ruth Brodie
- IPO
- 2018
- Employees
- 208
- HQ
- Vancouver, BC, CA
Price Chart
+12.99% · this period
Valuation
- Market Cap
- $29.22M
- P/E
- -22.22
- P/S
- 0.48
- P/B
- 0.74
- EV/EBITDA
- -23.09
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 20.98%
- Op Margin
- -8.94%
- Net Margin
- -2.27%
- ROE
- -3.16%
- ROIC
- -9.86%
Growth & Income
- Revenue
- $59.45M · 22.08%
- Net Income
- $1.05M · 141.02%
- EPS
- $0.02 · 135.96%
- Op Income
- $1.82M
- FCF YoY
- -749.61%
Performance & Tape
- 52W High
- $0.73
- 52W Low
- $0.39
- 50D MA
- $0.51
- 200D MA
- $0.51
- Beta
- 0.37
- Avg Volume
- 71.57K
Get TickerSpark's AI analysis on ROMJ.V
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our ROMJ.V Coverage
We haven't published any research on ROMJ.V yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate ROMJ.V Report →Similar Companies
LABS.TO+0.00%
MediPharm Labs Corp.
$0.08
CWEB.TO+0.00%
Charlotte's Web Holdings, Inc.
$0.59
AVCN.TO+0.00%
Avicanna Inc.
$0.13
VM.V+0.00%
Voyageur Pharmaceuticals Ltd.
$0.10
ADK.V-2.50%
DIAGNOS Inc.
$0.20
MBX.TO+2.22%
Microbix Biosystems Inc.
$0.23
IZO.CN-9.26%
Izotropic Corporation
$0.24
BUX.CN+5.36%
BioMark Diagnostics Inc.
$0.59